What's breaking now, across thousands of outlets.
(RTTNews) - Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company, announced late Tuesday the pricing of public offerings of common stock, pre-funded warrants and convertible senior notes for total proceeds of approximately $1.0 billion.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
A marital dispute resulted in gunfire at DAV Market in Firozabad on Tuesday night. Rishabh Tailang allegedly shot his wife Shipra and her suspected boyfriend Jitendra Thakur multiple times.
Mumbai: The Reserve Bank of India has flagged elevated valuations of artificial intelligence-related assets as one of the key downside risks to the global economic outlook, alongside geopolitical…
Le « Financial Time » a révélé mardi que la firme du milliardaire, SpaceX, a lancé une opération visant à financer l’achat de puces pour équiper ses data centers.
SEOUL, Oct. 7 (Yonhap) -- South Korean stocks dipped by nearly 2 percent on Wedn...
“The reality that private equity is interviewing so early in a banker’s career is very unfortunate, and to some extent, disappointing,” one Citi executive said.
Amid various macro uncertainties, interest in private credit declined sharply to 48 per cent from 71 – among alternative investments – while interest in real estate jumped to 52 from 39 per cent…
